Isatuximab Plus Carfilzomib–dexamethasone Versus Carfilzomib–dexamethasone in Patients with Relapsed Multiple Myeloma (IKEMA): Overall Survival Analysis of a Phase 3, Randomised, Controlled Trial

Kwee Yong,Thomas Martin,Meletios-Athanasios Dimopoulos,Joseph Mikhael,Marcelo Capra,Thierry Facon,Roman Hajek,Ivan Špička, Ross Baker,Kihyun Kim,Gracia Martinez,Chang-Ki Min,Ludek Pour,Xavier Leleu,Albert Oriol,Youngil Koh,Kenshi Suzuki,France Casca,Sandrine Macé,Marie-Laure Risse

The Lancet Haematology（2024）

Cited 0|Views3

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined